FURIN and anthrax infection: Importantly, the discovery of small-molecule furin inhibitors, notably a series of 2,5-dideoxystreptamine derivatives with nanomolar potency that protect cells from anthrax PA toxicity, represents a critical next step in the realization of therapeutic furin inhibitors [108,109,110].